Related Experiment Video
Updated: Jul 3, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Electroacupuncture efficacy in diabetic polyneuropathy: Study protocol for a double-blinded randomized controlled
María Fernanda Pérez Hernández1,2,3, Alejandra Calderón Vallejo4, Sergio de Jesús Aguilar Castillo5
1Unidad de Investigación Médica en Bioquímica, Unidad Médica de Alta Especialidad "Dr. Bernardo Sepúlveda", Centro Médico Nacional Siglo XXI, IMSS, Mexico City, 06720, Mexico.
Electroacupuncture (EA) may improve nerve conduction and symptoms in diabetic peripheral neuropathy (DPN) patients. This randomized trial investigates EA
Area of Science:
- Neurology
- Diabetology
- Integrative Medicine
Background:
- Diabetic peripheral neuropathy (DPN) is a common complication of type 2 diabetes mellitus (T2DM).
- Current treatments for DPN have adverse effects, prompting investigation into alternative therapies like electroacupuncture (EA).
- The efficacy and mechanisms of EA for DPN remain unclear, necessitating rigorous clinical investigation.
Purpose of the Study:
- To investigate the effectiveness of electroacupuncture (EA) as a treatment for diabetic peripheral neuropathy (DPN).
- To compare EA with sham EA in patients with T2DM and DPN.
- To explore the potential mechanisms of EA, including its effects on nerve conduction, symptoms, oxidative stress, inflammation, and gene expression.
Main Methods:
- A four-armed, randomized, controlled, multicenter clinical trial involving 48 T2DM patients with DPN.
- Patients were randomized to receive either EA or sham EA, stratified by DPN type (short fiber or axonal).
- The intervention comprised 32 sessions of EA/sham EA over 20 weeks, with assessments of nerve conduction, symptoms, pain, quality of life, oxidative stress, inflammation, and gene expression.
Main Results:
- Primary outcome: Nerve Conduction Study (NCS) parameters.
- Secondary outcomes: DPN symptoms and pain (MNSI, MDNS, DN-4, NRS), quality of life (SF-36).
- Exploratory outcomes: Oxidative stress, inflammatory response, and genetic expression.
Conclusions:
- This trial will compare EA versus sham EA for DPN management.
- EA may improve NCS parameters, neuropathic pain, and symptoms.
- EA could be a potential coadjuvant treatment for DPN, possibly with a remyelinating effect.
More Related Videos
04:33Effects of Different Connection Modes of Electroacupuncture on Electrocardiogram and Nerve Discharge in Rats
Published on: January 3, 2025
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023